Navigation Links
Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
Date:3/20/2012

IRVING, Texas, March 20, 2012 /PRNewswire/ -- Novation, the leading health care supply contracting company, announces the release of its most recent Transcatheter Cardiovascular Therapeutics Report.  This report is produced by Novation's cardiology staff and is intended to help VHA, UHC and Provista members understand and prepare for new cardiology technologies.

The Novation cardiology team compiled this report following their attendance late last year at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting.  The TCT is the world's largest educational meeting specializing in interventional cardiovascular medicine and the latest advances in current therapies and clinical research.  The conference also showcases technologies and devices not yet available in the United States.

By attending the TCT meeting and learning about new trends and devices, the Novation cardiovascular team can advise members about the impact of upcoming technologies before they are approved by the U.S. Food and Drug Administration. 

Novation's report focuses on several emerging technologies and trends. Areas of focus in this report include transcatheter aortic valve replacement, high blood pressure therapy, drug-eluting balloons, and bioabsorbable coronary stents, as well as coronary, peripheral vascular, structural heart, and heart rhythm products and technology trends.

Some of the devices, such as the percutaneous heart valves, have recently been approved. Other products, such as the drug-eluting balloon, bioabsorbable coronary stent and renal denervation, are in clinical trials and device development, but demonstrate promising early results. This report highlights these and other new cardiovascular devices in a condensed format.

"The intent of our report is to provide clinical and economic highlights of these new technologies that have a high probability of impacting the member hospitals we serve," said Michael Vintges, vice president, physician preference, contract and program services, Novation.  "Novation is committed to helping the hospitals we serve continue to provide the highest quality care, while simultaneously driving supply costs down."

To view the entire report, please visit https://www.novationco.com/pressroom/industry_info.

About Novation, Winner of the Ethics Inside® Certification

Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Tex, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase more than $40 billion in products and services in 2011. Novation recently earned the coveted Ethics Inside® Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care group purchasing organization to earn this distinction.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
4. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
5. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
6. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
9. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
10. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
11. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
Breaking Medicine News(10 mins):